
Sign up to save your podcasts
Or


The Chinese AI company doesn’t want to bother with funding—at least not right now. WSJ reporter Rebecca Feng discusses why DeepSeek is so hesitant. Plus, how will federal funding cuts impact drug development? WSJ enterprise technology bureau chief Steven Rosenbush explains the impact on the bioscience industry. Shara Tibken hosts.
Sign up for the WSJ's free Technology newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By The Wall Street Journal4.3
15931,593 ratings
The Chinese AI company doesn’t want to bother with funding—at least not right now. WSJ reporter Rebecca Feng discusses why DeepSeek is so hesitant. Plus, how will federal funding cuts impact drug development? WSJ enterprise technology bureau chief Steven Rosenbush explains the impact on the bioscience industry. Shara Tibken hosts.
Sign up for the WSJ's free Technology newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices

2,847 Listeners

1,730 Listeners

982 Listeners

4,401 Listeners

407 Listeners

437 Listeners

684 Listeners

1,449 Listeners

1,044 Listeners

1,314 Listeners

6,119 Listeners

1,579 Listeners

1,324 Listeners

585 Listeners

151 Listeners

63 Listeners

80 Listeners

146 Listeners